Neoprofen is owned by Recordati Rare.
Neoprofen contains Ibuprofen Lysine.
Neoprofen has a total of 1 drug patent out of which 0 drug patents have expired.
Neoprofen was authorised for market use on 13 April, 2006.
Neoprofen is available in injectable;intravenous dosage forms.
The generics of Neoprofen are possible to be released after 02 March, 2032.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.|
|US8415337||RECORDATI RARE||Ibuprofen compositions and methods of making same|| |
(9 years from now)
Market Authorisation Date: 13 April, 2006
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic